Humana (NYSE: HUM) is reorienting the hospice segment of its Kindred At Home subsidiary as a standalone business in anticipation of a forthcoming sale. The company also pledged to boost its overall enterprise value by an additional $1 billion, though Humana is still working out the timeframe in which they expect to hit that target. […]
This year was transformational for the hospice space. The industry took its first steps towards value-based payment through the hospice component of the value-based insurance design model, or Medicare Advantage hospice carve-in. Providers also saw an overhaul of the U.S. Centers for Medicare & Medicaid Services’ (CMS) survey process, all while contending with COVID-19 headwinds […]
The advent of value-based programs such as the hospice component of the value-based insurance design (VBID) demonstration hold financial promise for providers — as well as risks. As the hospice component of VBID nears the end of its first year, some providers are seeing gaps between how the program is designed and how it is […]
Despite prevailing COVID-19 headwinds, the hospice and home health mergers and acquisitions market shows no signs of slowing. Labor shortages plaguing the industry may be spurring additional activity as the dwindling workforce is limiting some providers’ ability to grow organically. A number of the larger strategic buyers — LHC Group (NASDAQ: LHCG), Amedisys (NASDAQ: AMED), […]
Humana (NYSE: HUM) is currently migrating Kindred at Home’s home health services into its health care service brand, CenterWell. The company will be focused on expanding the acquired asset’s footprint in select markets in North Carolina and Virginia in 2022 as it paves the way for a hospice spin off. Humana in April completed the […]
Private equity investors remain bullish on hospice with no signs of slowing down. However, with a number of high-profile transactions completed or in the works during 2020 and 2021, the number of hospices of scale that are likely to come to market is dwindling. During the next few years, PE firms will likely fix their […]
Humana, Inc. (NYSE: HUM) has completed its purchase of Kindred at Home in an $8.1 billion transaction. The company obtained a 40% stake in Kindred in 2018. Through this transaction Humana gains the remaining 60% from private equity firms Welsh, Carson, Anderson & Stowe (WCAS) and TPG Capital. The price tag includes Humana’s equity value […]
The U.S. Senate Finance Committee is investigating private equity interest in the home health and hospice provider Kindred at Home. The move reflects growing concern among lawmakers about the impact of private equity’s involvement in hospice. The private equity firms Welsh, Carson, Anderson & Stowe (WCAS) and TPG Capital in 2018 acquired a combined 60% […]
The hospice mergers and acquisitions market has been exploding in recent years, continuing to gain momentum despite pandemic-related pitfalls. Still, hospices need to tread lightly and keep a close watch on where they measure up in the highly competitive market, with quality and compliance posing the greatest risks to their value propositions, according to M&A […]
New York-based private equity firm Welsh, Carson, Anderson & Stowe (WCAS) has launched a portfolio company called Valtrius that will invest in companies oriented around value-based care. The firm’s initial investment totaled $300 million. WCAS has invested nearly $10 billion during the past 40 years in more than 90 health care companies via 13 private […]
By continuing to use the site, you agree to the use of cookies. more information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
